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Abstract
Background: The risk of aortic dissection is 100-fold increased in Turner syndrome (TS). Unfortunately, risk
stratification is inadequate due to a lack of insight into the natural course of the syndrome-associated aortopathy.
Therefore, this study aimed to prospectively assess aortic dimensions in TS.
Methods: Eighty adult TS patients were examined twice with a mean follow-up of 2.4 ± 0.4 years, and 67 healthy
age and gender-matched controls were examined once. Aortic dimensions were measured at nine predefined
positions using 3D, non-contrast and free-breathing cardiovascular magnetic resonance. Transthoracic
echocardiography and 24-hour ambulatory blood pressure were also performed.
Results: At baseline, aortic diameters (body surface area indexed) were larger at all positions in TS. Aortic dilation
was more prevalent at all positions excluding the distal transverse aortic arch. Aortic diameter increased in the
aortic sinus, at the sinotubular junction and in the mid-ascending aorta with growth rates of 0.1 - 0.4 mm/year.
Aortic diameters at all other positions were unchanged. The bicuspid aortic valve conferred higher aortic sinus
growth rates (p < 0.05). No other predictors of aortic growth were identified.
Conclusion: A general aortopathy is present in TS with enlargement of the ascending aorta, which is accelerated
in the presence of a bicuspid aortic valve.
Background
The incidence of aortic dissection is 100-fold increased
in Turner syndrome (TS) [1-3], where aortic dilation,
bicuspid aortic valve (BAV), aortic coarctation, karyo-
type 45X and hypertension confer increased risk of dis-
section [4-7]. However, these risk markers are not
identified in all aortic dissections in TS [4,5] and aortic
follow-up is therefore recommended for all patients [8].
Cross-sectional studies show a high prevalence of aor-
tic dilation at all ages in TS [6,7,9,10] whilst knowledge
of the development of the aortopathy over time is lim-
ited. Only one transthoracic echocardiography study
(TTE) has prospectively assessed aortic dimensions in
TS [11]. In this study the ascending aorta was seen to
enlarge over 37-months but aortic growth could not be
associated with the risk markers for aortic dissection in
TS [11]. However, TTE is not the most likely modality
to provide successful imaging in TS [12,13] where
assessment of the entire aorta is of key importance
because the arteriopathy extends beyond the ascending
aorta [6,14] and a fifth of dissections occur in the des-
cending aorta [4,5]. In contrast to this, 3D cardiovascu-
lar magnetic resonance (CMR) offers more optimal non-
radiation imaging of the entire thoracic aorta that is
applicable to most TS patients [6,13] and ideal for serial
aortopathy assessment.
In the present study we set out to provide prospective
data on the aortopathy in TS using highly sensitive 3D,
free-breathing and contrast-free CMR [15]. By use of
this modality we aimed to study aortic growth, as it is
an important surrogate marker for aortic dissection that
adds prognostic information to cross-sectionally assessed
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associations between aortic growth and the currently
used risk markers for aortic dissection.
Methods
Study Population
Patients with karyotypically proven TS (n = 102) were
recruited through the Danish National Society of Turner
Syndrome Contact Group and an endocrine outpatient
clinic. Exclusion criteria included malignancy, liver dis-
ease and contraindications to CMR (including mechani-
cal aortic valve prosthesis). Healthy, age-matched
females (n = 67) were recruited by advertisement to
s e r v ea sb a s e l i n ec o n t r o l s .T h ep a t i e n t sw e r ee x a m i n e d
at baseline and follow-up with CMR, TTE and 24-hour
ambulatory blood pressure monitoring. The controls
were examined once.
The study was conducted in compliance with the Hel-
sinki Declaration. Aarhus County Ethical Scientific
Committee (Denmark) approved the trial protocol (#
20010248). All participants gave informed consented.
Cardiovascular Magnetic Resonance Imaging
CMR was performed with a 1.5 Tesla whole-body mag-
netic resonance scanner (ACS-NT, Philips Medical Sys-
tems; maximum gradient performance 30 Tesla per
meter amplitude, slew rate 150 Tesla/m/sec). A 5-ele-
ment cardiac coil was used. After initial scouts, a 3D
data stack (27 cm [AP] × 15 cm [FH] × 36 cm [LR])
covering the entire thoracic aorta was acquired. A con-
trast-free, nearly isotropic, fat-saturated, 3D steady-state
free precession and ECG-triggered gradient echo
sequence (250 ms diastolic acquisition window) with a
respiratory navigator was used [6,14]. All patients were
examined by the same staff and in the same scanner.
Systematic analysis was performed using dedicated
software (Systematic Software Engineering, Aarhus,
Denmark), allowing reconstruction of the 3D stack of
data in any plane (Figure 1) [6,14]. All CMR scans were
reviewed for morphologic abnormalities of the aorta and
the major branch arteries. Abnormalities were defined
according to the previously used definitions: (i) aortic
coarctation, (ii) elongated transverse aortic arch, (iii)
aberrant right subclavian artery, and (iv) bovine aortic
arch [14].
Two CMR experienced observers measured true cross-
cut, perpendicular and maximum aortic diameters
(Figure 1, 2, 3). The observers were blinded to the clini-
cal data of the patient. Aortic or extra-aortic landmarks
guided the measurement positions. The positions were:
(i) aortic sinuses (measuring cusp-to-opposing-cusp dia-
meter at the point of the maximum aortic diameter in
the aortic sinus [Figure 3]), (ii) ascending aorta at the
sinotubular junction; (iii) mid-ascending aorta at the
level of the inferior margin of right pulmonary artery;
(iv) distal ascending aorta immediately proximal to bra-
chiocephalic artery; (v) proximal aortic arch between
the brachiocephalic and left carotid artery arteries; (vi)
distal aortic arch immediately proximal to left subcla-
vian artery; (vii) aortic isthmus immediately distal to the
left subclavian artery; (viii) proximal descending aorta
between the left pulmonary artery and the top of left
a t r i u m :a n d :( i x )distal descending aorta at the most
caudal border of the left atrium. At these positions (Fig-
ure 2), two imaging planes perpendicular to each other
and to the measurement plane were simultaneously dis-
played to ensure a correct measurement (Figure 1). All
measurements were obtained as maximum intra-luminal
diameter, defined by the high-intensity signal in the ves-
sel lumen on steady state free precession CMR (Figure
3). Measurements were taken without assumptions of
circular anatomy of the aortic lumen.
The baseline measurement planes (Figure 1) were
stored and subsequently used to guide the re-assessment
of the aortic diameters at follow-up, ensuring that fol-
low-up measurements were taken as close as possible to
the baseline measurement positions. These stored base-
line images were blinded for the previously obtained
measurements. Baseline and follow-up measurements
were not taken at the same time from the collected data
sets.
Two observers measured 20 randomly chosen CMR
scans to determine interobserver measurement variabil-
ity. This was carried out according to the measurement
methodology described above, where one observer
defined the measurement plane and the stored this
plane in a blinded format (Figure 1). The second obser-
ver then re-measured the diameter using this plane to
adjust their measurement position. After this, one obser-
ver re-measured these 20 scans to assess intraobserver
measurement variability using the same approach. Dur-
ing this re-measurement the observer was blinded to the
previously obtained measurements and to whether they
were measuring a follow-up scan or re-measuring a
baseline scan (i.e. 100 scans were assessed in random
order, comprising 80 follow-up scans mixed with
20 repeat baseline measurements).
Aortic dilation was defined as a diameter exceeding
two standard deviations above the mean of the control
group. All measurements were indexed for body surface
area (BSA) [7].
Echocardiography and Blood pressure
One experienced observer performed TTE on a GE
Vivid Seven (GE Healthcare, Horten, Norway) with a 2.5
mHz transducer using second harmonic imaging. Aortic
valve morphology and function were assessed. Leaflet
morphology was registered in BAV patients: fusion of
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fusion, and left and non-coronary fusion [17]. Aortic
stenosis was diagnosed from Doppler tracings, and clas-
sified as mild (mean gradient below 25 mm Hg), moder-
ate (mean gradient 25 to 40 mm Hg) or severe (mean
gradient above 40 mm Hg) [18]. Aortic regurgitation
was defined from colour Doppler as the width of the
vena contracta in the parasternal long axis view, and
classified as mild (above 0.3 cm), moderate (0.3 to 0.6
cm) or severe (above 0.6 cm) [18].
Figure 1 Aortic measurements by multiplanar reformatting. Multiplane reformatting was used to map diameters of the aorta in a
measurement plane that was perpendicular to the direction of blood flow and orthogonal to the aortic wall at the position of measurement.
Aortic and extra-aortic anatomical landmarks defined these positions. Here, the positioning of the measurement plane (Plane A) is schematically
demonstrated for the aortic sinus in a patient with Turner syndrome and tricuspid aortic valve morphology.
Figure 2 Measurements positions from 3D CMR. Measurements were obtained from nine positions along the thoracic aorta, spanning from
aortic sinus level to the distal descending aorta. Each measurement position was adjusted using 3D multiplanar reformatting, which was guided
by local aortic and extra-aortic landmarks as well as the shape and dimensions of the aortic lumen.
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24-hours with oscillometric measurements every 20 min-
utes (SpaceLabs 91207, Washington, USA). The cuff was
positioned on the left arm and cuff size was adjusted to
the upper arm circumference.
Statistical analyses
Statistical computations were performed using SPSS
18.0 and GraphPad Prism 5.0. Normal distribution of
data was tested with Shapiro-Wilk test. Continuous vari-
ables are expressed as means ± standard deviations.
Data was compared using Student’s independent t-test
or paired t-test. Correlations were assessed by Pearson’s
coefficient of correlation or binomial distribution with
either the c
2 test (if the expected distribution was > 5 in
all cells) or Fisher’s exact test (if the expected distribu-
tion was ≤ 5 in one or more cells). Backward multiple
linear regression was used to examine the principal
determinants of aortic growth rates, where independent
variables were omitted from the model when p > 0.1.
Otherwise, p < 0.05 was considered statistically signifi-
cant. CMR reproducibility was tested with Bland-Altman
analysis, where a linear approach was taken after ensur-
ing that the degree of variability did not vary systemati-
cally with the measured diameters [19].
Results
Study population
Eighty of 102 recruited TS patients completed the fol-
low-up. At baseline, one patient was diagnosed with
chronic Stanford type A dissection, which led to exclu-
sion from the study. Between baseline and follow-up,
one patient had aortic valve replacement for severe
aortic valve stenosis, and she was excluded. Three
patients died during the follow-up (one from cardio-
genic shock after surgery for severe aortic dilation [max-
imum aortic diameter 49.7 mm in the mid-ascending
aorta]; one from unexplained sudden death [maximum
aortic diameter 39.0 mm in the aortic sinus at baseline];
and one from an epileptic seizure). No autopsies were
performed. Eight patients withdrew their consent for
non-health related reasons before follow-up. No cardio-
vascular events occurred during follow-up in patients
who completed the study or withdrew their consent. In
9 patients, either baseline or follow-up CMR scans were
not usable, mainly because of poor patient compliance
but in a few cases for technical reasons; all 9 patients
declined repeat imaging.
The mean follow-up interval for the 80 patients with
TS who completed both baseline and follow-up CMR
was 2.4 ± 0.4 years (range: 1.4 - 3.5 years). Patient and
control characteristics are given in Table 1, and baseline
characteristics for the entire baseline cohort have been
described previously [6].
Aortic valve morphology could not be determined in
one patient; BAV was present in 22 patients (28%) and
tricuspid aortic valve (TAV) was seen in 57 patients
(71%). The right and left coronary cusps were fused in
18 (82%) of patients with BAV, the right and non-cor-
onary cusps were fused in 4 patients (18%), and none
had fusion of the left and non-coronary cusps. In TS,
the aortic valve was regurgitant in 17 patients (21% [15
were mild and 2 were moderate, while none were
severe]) and stenotic in 9 patients (11% [7 were mild
and 2 were moderate, while none were severe]). Aortic
stenosis and regurgitation co-existed in 5 TS patients
Figure 3 Aortic diameter measured from 3D multiplanar reformatted CMR. Aortic diameter was obtained as the maximum diameter of the
high intensity signal of the blood pool within the vessel lumen on 3D non-contrast enhanced, balanced steady state free precession CMR. No
assumptions of circular anatomy were made. At the level of the aortic sinus, cusp-to-opposing-cusp diameters were obtained for the optimum
diameter assessment as shown here for the aortic sinus in a patient with Turner syndrome and bicuspid aortic valve morphology.
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stenosis (of any degree) were more likely to be present
in patients with BAV than TAV (for aortic stenosis: 8
patients (36%) with BAV and 1 (2%) with TAV [p =
0.001], and for aortic regurgitation: 9 patients (41%)
with BAV and 8 patients (14%) with TAV [p = 0.04]).
Predefined arch anomalies are given in Table 1. All con-
trols had normal aortic valve morphology and two (3%)
had mild aortic valve regurgitation, while none had aor-
tic stenosis.
Baseline aortic measurements were comparable in the
80 patients with TS, who participated in the follow-up,
when compared to those who did not complete the fol-
low-up.
Aortic dimensions and growth
Absolute aortic diameters in TS and controls were com-
parable at all regions except the distal transverse aortic
arch and the aortic isthmus, where the aorta was smaller
in TS (p < 0.05). In contrast to this, BSA-indexed aortic
diameters were enlarged at all positions in TS (p <
0.05). Only at the sinotubular junction was the preva-
lence of absolute aortic dilation higher in TS (10% in TS
versus 2% in controls, p = 0.04), while the prevalence of
BSA-indexed dilation was much more common (Table
2). BAV, aortic coarctation, elongated transverse aortic
arch, blood pressure elevation (systolic and diastolic),
age and karyotype 45X were associated with larger base-
line aortic diameters in TS [6,14].
At follow-up increases in aortic diameter were limited
to the aortic sinuses, the sinotubular junction and the
mid-ascending aorta (Table 2). The presence of BAV
associated with more pronounced aortic growth (abso-
lute; follow-up time-weighted absolute; and indexed for
both follow-up time and BSA) at sinus level only (BAV
versus TAV: 1.64 ± 2.19 versus 0.69 ± 1.71 mm [p =
0.04]; 0.64 ± 0.84 versus 0.26 ± 0.62 mm/year [p =
0.04]; and 0.44 ± 0.57 versus 0.18 ± 0.61 mm/year/m
2 [p
= 0.03]). The type of BAV cusp morphology did not
associate with aortic growth. Age was comparable in
patients with TAV and BAV (p = 0.9). Increments in
aortic sinus diameter were not exclusive to patients with
BAV, as they were also seen in TAV (baseline versus
follow-up diameter in TAV: 28.5 ± 3.5 versus 29.2 ± 3.9
mm [p < 0.001]). No other aortic measurement position
was found to have similar associations with BAV.
Table 1 Demographics and descriptives in Turner syndrome and controls
Turner syndrome Controls
n=8 0 n=6 7
Baseline age (years [range]) 38 ± 10 [18 - 60] 39 ± 12 [20 - 63] ***
Body surface area (m
2) 1.5 ± 0.2 1.8 ± 0.2 **
Karyotype (45X/non-45X, %) 60%/40% -
Growth hormone substitution
a
Treated (%) 28% -
Exposure time (years) 5 ± 3 -
Estrogen substitution
a
Treated (%) 85% -
Exposure time (years) 19 ± 9 -
Aortic abnormalities
Elongated transverse aortic arch 48% -
Aortic coarctation 11% -
Previous coarctation repair 9% -
Aortic arch hypoplasia 2% -
Bovine aortic arch 8% 8%
Aberrant right subclavian artery 10% -
Baseline Follow-up
Antihypertensive treatment 30% 46%
Ambulatory blood pressure
24-hour systolic (mm Hg) 122 ± 14 120 ± 12 * 113 ± 11 **
24-hour diastolic (mm Hg) 78 ± 11 76 ± 9 * 71 ± 8 **
24-hour heart rate (beats/min) 77 ± 9 75 ± 8 * 71 ± 9 **
Continuous variable are expressed as means ± standard deviations.
* P < 0.05 using Student’s paired t-test to compare Turner syndrome at baseline and follow-up.
** P < 0.05 using Student’s independent t-test to compare Turner syndrome at baseline to controls.
*** P > 0.05 using Student’s independent t-test to compare Turner syndrome at baseline to controls
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were further evaluated by multiple linear regression mod-
els, using aortic growth rate as the dependent variable.
The independent variables were chosen from baseline
correlations with aortic diameter [6,14]. Models incorpor-
ating these variables were only significant at the level of
the aortic sinus. One model (R = 0.26, p = 0.03) had aor-
tic growth rate at sinus level as the dependent variable,
where aortic valve morphology was the only explanatory
variable, while age, 24-hour systolic blood pressure, BSA
and antihypertensive treatment did not contribute.
Baseline aortic diameters, aortic dilation, aortic valve
function and aortic coarctation were not related to aor-
tic growth at any position (neither with or without
indexing for follow-up time). The presence of an elon-
gated transverse aortic arch was associated with lower
growth rates (absolute and BSA-indexed) in the distal
transverse aortic arch and proximal ascending aorta (p <
0.05). Karyotype 45X conferred less rapid growth rates
in the distal aortic arch (p = 0.002) and in the proximal
descending aorta (p = 0.006). None of the following
variables were found to relate with aortic growth (abso-
lute or BSA-indexed): age, estrogen replacement ther-
apy, previous growth hormone treatment, baseline blood
pressure, changes in blood pressures during follow-up
or antihypertensive treatment.
In 31 (39%) of the TS patients the increase in aortic
diameter exceeded the interobserver limits of agreement
in one or more positions (but never in the proximal
arch or the aortic isthmus). These mainly affected the
ascending aorta (29/31 [94%]), involving the aortic sinus
(24/31 [77%]), the sinotubular junction (6/31 [19%]) and
the mid-ascending aorta (12/31 [39%]). Aortic valve
morphology, aortic arch abnormalities, aortic dilation
(absolute or BSA indexed) or antihypertensive treatment
were not more common in patients with such appar-
ently fast growing aortas. However, this subset did have
marginally higher 24-hour heart rates (p = 0.08),
whereas blood and pulse pressures (or changes in the
24-hour ambulatory blood pressure parameters during
follow-up) were not different.
Nineteen patients (24%) had annual growth rates that
exceeded two standard deviations above the mean
change for the whole TS group; no risk marker was
more prevalent in this group.
Blood pressure and Heart rate
Baseline blood pressures were higher in TS than in con-
trols even though 30% of the patients (24/80) took anti-
hypertensive medication at baseline (Table 1). At follow
up, the number of patients on antihypertensive medica-
tion had increased to 46% (37/80) with a concomitant
blood pressure and heart rate reduction (Table 1). All
antihypertensive medication was prescribed for elevated
blood pressures rather than for aortic dilatation and
dissection prophylaxis.
Reproducibility of CMR
The intra- and interobserver measurement variability
was low (Table 3). There was no systematic variation at
any aortic region of interest to suggest bias, or with
increasing or decreasing aortic diameter.
Table 2 Aortic dilation and aortic growth in Turner syndrome
Aortic dilation
a Aortic diameter and growth
Turner syndrome Controls Turner syndrome
Baseline Change Change rate
b
n=8 0 n=6 7 n=8 0 n=8 0 n=8 0 n=8 0
% % mm mm mm/year mm/year/m
2
Aortic sinus 18.9* 1.5 29.2 ± 3.9 1.0 ± 1.9** 0.38 ± 0.7 0.26 ± 0.5
Sinotubular junction 30.3* 2.9 25.3 ± 4.3 0.4 ± 1.3** 0.11 ± 0.5 0.07 ± 0.3
Mid-ascending aorta 36.7* 1.5 27.5 ± 5.0 0.6 ± 1.4** 0.24 ± 0.6 0.16 ± 0.4
Distal ascending aorta 33.3* 2.9 25.3 ± 3.6 -0.1 ± 1.0 -0.01 ± 0.4 -0.01 ± 0.3
Proximal transverse aortic arch 24.1* 3.6 23.4 ± 3.6 0.1 ± 0.9 -0.01 ± 0.4 -0.01 ± 0.2
Distal transverse aortic arch 10.3 3.0 20.5 ± 2.7 0.1 ± 0.8 0.01 ± 0.4 0.01 ± 0.3
Aortic isthmus 14.1* 3.0 19.3 ± 2.3 0.1 ± 0.8 0.05 ± 0.4 0.03 ± 0.3
Proximal descending aorta 34.2* 1.5 19.5 ± 2.8 -0.1 ± 0.8 -0.01 ± 0.3 -0.01 ± 0.2
Distal descending aorta 30.7* 1.5 18.2 ± 2.2 -0.1 ± 0.6 -0.03 ± 0.3 -0.02 ± 0.2
Continuous variables are expressed as means ± standard deviations.
a Aortic dilation is defined by the mean + 1.96 standard deviations in the controls, and calculated from body surface area indexed diameters.
b Aortic growth rates are calculated as the individual change in diameter from baseline to follow-up weighted individually for the duration of the follow-up.
* P < 0.05 using chi-square or Fisher’s exact 2-sided test to compare Turner syndrome to controls.
** P < 0.05 using Student’s paired t-test to compare baseline aortic diameter to follow-up in Turner syndrome.
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This prospective CMR study documents the progressive
nature of aortic dilation in TS. In keeping with a pro-
pensity towards ascending aortic dilation and dissection
in TS [4,5], the process of dilation was found to affect
the aortic sinus, the sinotubular junction and the mid-
ascending aorta. Furthermore, the present study pro-
vides novel evidence to the adverse impact of BAV mor-
phology on aortic growth rates in TS, as only previously
indicated by cross-sectional studies [6,9,12].
The only preceding, longitudinal evaluation of aortic
dimensions in TS used TTE and failed to identify predic-
tors of aortic growth [11]. However, limited acoustic win-
dows in coexistence with a complex aortopathy in the
entire thoracic aorta render TTE less beneficial in TS
[12,13]. In contrast to TTE, the present CMR sequence
facilitated a comprehensive assessment of the thoracic
aorta without limitations of acoustic windows and with
high-reproducibility post-processing of 3D data. The cur-
rent CMR methodology thus provided optimised aortic
assessment in TS, which should always include a com-
plete view of the thoracic aorta even though we did not
detect aortic growth beyond the mid-ascending aorta on
whole group analysis. This need for evaluation of the
entire thoracic aorta beyond the ascending aorta is justi-
fied in the present study not only by highly abnormal
descending aortic diameters and very frequent pathology
in the transverse aortic arch but also by the presence of
increasing descending aortic diameters in some, indivi-
dual TS patients in our cohort. Additionally, this need for
a comprehensive delineation of aortic morphology is sup-
ported by the previously demonstrated occurrence of aor-
tic dissections in the descending aorta in TS [4].
Consequently, TTE should in our opinion be restricted
to follow-up in patients where aortic morphology is
proven to be normal in the context of adequate acoustic
windows. Our stance corresponds well with recent guide-
lines for diagnosis and monitoring of thoracic aortic dis-
ease, where TTE was deemed problematic for serial
assessment of aortic calibre when pathology extends
beyond the sinotubular junction [16]. Collectively, non-
contrast and non-radiation investigations should be the
gold standard for serial aortic assessment in TS, where
imaging must provide sufficient aortic overview that is
free from acoustic limitations and ideally provide repro-
ducible 3D data. As a consequence of this, our method
and findings are applicable beyond the research setting
because 3D data was acquired without the use of radia-
tion or contrast and with a short total scan time (on
average 10-15 minutes). Furthermore, the present recruit-
ment method ensured inclusion of a representative spec-
trum of TS phenotypes covering a wide age range, which
makes our findings on aortic growth rates applicable as a
CMR reference to the general adult TS population. Sup-
porting this degree of external validity, the prevalence of
congenital cardiac abnormalities was comparable to pre-
vious studies [20].
The presence of BAV was associated with more rapid
growth in the aortic sinus than seen in patients with
TAV. However, even though abnormal valve morphol-
ogy was of prognostic importance, ascending aortic dia-
meter also increased in patients with normal valve
morphology over 2.4 years. Additionally, and irrespective
of aortic valve morphology, the observed aortic growth
rates in TS exceeded annual growth rates of 0.07 mm as
previously demonstrated in healthy females using 2D
CMR [21], and they were at least comparable to those
demonstrated in patients with BAV morphology found
to be 0.19 mm/year using a spectrum of imaging modal-
ities [22]. Therefore, patients with TS appear to suffer
Table 3 Measurement variability of multiplanar aortic CMR measurements
Intraobserver Interobserver
Mean difference
a Limits of agreement
b Mean difference
a Limits of agreement
b
mm mm mm mm
Aortic sinus -0.04 -1.9 - 1.8 0.1 -2.1 - 2.3
Sinotubular junction 0.02 -1.8 - 1.9 -0.3 -2.3 - 1.8
Mid-ascending aorta -0.1 -1.9 - 1.8 -0.1 -1.9 - 1.4
Distal ascending aorta -0.1 -1.9 - 2.1 0.1 -1.6 - 1.7
Proximal transverse aortic arch 0.2 -1.6 - 2.0 -0.2 -1.4 - 1.9
Distal transverse aortic arch 0.01 -1.7 - 1.7 -0.01 -1.6 - 1.4
Aortic isthmus 0.1 -1.6 - 1.4 -0.1 -1.4 - 1.9
Proximal descending aorta 0.08 -1.5 - 1.4 0.08 -1.1 - 1.9
Distal descending aorta -0.06 -1.6 - 1.7 0.1 -1.2 - 1.5
Linear Bland-Altman analysis of inter- and intraobserver variability in the setting of repeat, maximum aortic diameter measurements with CMR using multiplanar
reformatting of 3D non-contrast, free-breathing aortograms.
a Mean difference between the first and second measurement by the same observer, or between different observers.
b The limits of agreement are the mean difference ± 1.96 standard deviations.
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phology in this relatively short-term follow-up study. An
extended follow-up period could have revealed further
associations between aortic growth and other risk mar-
kers of dissection beyond aortic valve morphology,
which might include hypertension, karyotype 45,X or
aortic coarctation. This would be in line with previous
indications of a multifactorial aetiology of aortic disease
in TS, where aortic dissections occur even in the
absence of the presently acknowledged markers of aortic
dissection [4]. Consequently, risk stratification for aortic
dissection in TS should not solely be based on cross-
sectional aortic diameter and the presence of fixed risk
factors (BAV, hypertension, aortic coarctation and kar-
yotype); it should also include assessment of changes in
aortic diameter in TS to provide a more nuanced prog-
nostication. This inclusion of longitudinally assessed
aortic diameter in risk stratification for aortic dissection
was also acknowledged by the recent consensus guide-
lines on thoracic aortic disease [16].
The limits for surgical prophylaxis for aortic dissection
remain to be defined from larger prospective and hard-
endpoint studies in order to provide firm evidence-
based guidance for risk reduction in the aortopathy
associated with TS. The issue of initiation and choice of
medical prophylaxis through antihypertensive treatment
also remains unresolved in TS [3]. In the present study,
blood pressure levels were not associated with progres-
sive aortic dilatation, even though aortic diameter did
associate with blood pressure at baseline [6]. This
absence of association between blood pressure (or
changes herein during follow-up) and aortic growth
rates could be caused by the fact that participation in a
study with 24-hour blood pressure monitoring will diag-
nose new cases with hypertension and identify insuffi-
ciently treated hypertensive patients. Since the patients’
physicians were recommended to commence or intensify
antihypertensive treatment according to the blood pres-
sure readings, a larger fraction of patients were therefore
on antihypertensive medicines at follow-up with a range
of pharmacological interventions instituted. This is
highly likely to have influenced the association between
blood pressure and the process of aortic dilation. Thus,
despite the absence of association between aortic growth
and blood pressure, we believe that it is prudent to initi-
ate antihypertensive treatment with a low threshold in
TS, and conclusions on efficacy of specific antihyperten-
sive strategies can only be drawn from randomised con-
trolled trials.
Conclusions
An accelerated ascending aortopathy was present in
adult TS patients with growth rates of 0.1 - 0.4 mm/
year during 2.4 years of prospective CMR follow-up.
The presence of a BAV was associated with higher aor-
tic growth rates, whereas other markers of aortic dila-
tion and dissection did not correlate with aortic growth
rates in non-selected TS.
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